KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF- κB signaling pathway.
CONCLUSIONS: These results revealed that silencing KLF5 expression reduced the proliferation, migration and invasion and EMT abilities by inhibiting the NF-κB pathway in Hep-2 cells. Our results suggest that KLF5 may be a potential therapeutic target in laryngeal carcinoma.
PMID: 31115014 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Epithelial Cancer | Eyes | Genetics | Laryngeal Cancer | Study | Zinc